Neehar Dilip Parikh MD, MS

parikh-neehar
Li Ka Shing Research Professor of Hepatology
Associate Professor of Internal Medicine and Medical Director
Hepatology Living Donor Transplant
Medical School
[email protected]
Available to mentor
Neehar Dilip Parikh MD, MS
parikh-neehar
Associate Professor
  • Center Memberships
  • Recent Publications
  • Manage Your Profile

  • Center Memberships

    • Center Member
      Institute for Healthcare Policy and Innovation

    Recent Publications

    See All Publications
    • Journal Article
      Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations.
      Parikh ND, Liu C-C, DeMaio M, Yeh AH, Stackpole ML, Li S, Agopian VG, Li W, Zhou XJ, Ni X, Lok AS, Han S-HB. Hepatol Commun, 2026 Jul 1; 10 (7): DOI:10.1097/HC9.0000000000000987
      PMID: PMC13286316
    • Journal Article
      The future of blood-based biomarkers in liver cancer
      Singal AG, Saborowski A, Parikh ND, Banales JM. Journal of Hepatology, 2026 Jul 3; DOI:10.1016/j.jhep.2026.03.040
    • Journal Article
      Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic Regions.
      Toyoda H, Hoshida Y, Parikh ND, Jalal PK, Piñero F, Mendizabal M, Ridruejo E, Cheinquer H, Casadei-Gardini A, Kanneganti M, Weinmann A, Peck-Radosavljevic M, Dufour J-F, Radu P, Shiha G, Soliman R, Sarin SK, Kumar M, Wang J-H, Tangkijvanich P, Sukeepaisarnjaroen W, Atsukawa M, Uojima H, Nozaki A, Nakamuta M, Takaguchi K, Hiraoka A, Abe H, Matsuura K, Watanabe T, Shimada N, Tsuji K, Ishikawa T, Mikami S, Itobayashi E, Johnson PJ, Singal AG. Liver Int, 2026 Jul; 46 (7): e70734 DOI:10.1111/liv.70734
      PMID: 42257496
    • Journal Article
      Management and Prevention of Histotripsy-Induced Acute Bland Portal Vein Thrombosis in Histotripsy Treated Liver Tumors.
      Worlikar T, Caoili E, Navarro A, Loudon N, Nalla A, Khaykin VM, Hudson E, Hunold T, Parikh ND, Mendiratta-Lala M. J Vasc Interv Radiol, 2026 Jun 2; 108883 DOI:10.1016/j.jvir.2026.108883
      PMID: 42235819
    • Journal Article
      Corrigendum to "Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international study" [Surgery 183 (2025) 109396].
      Choi WJ, Ivanics T, Claasen M, Magyar CTJ, Li Z, Tabrizian P, Rocha C, Myers B, O'Kane GM, Reig M, Fàbrega JF, Holguín V, Parikh ND, Pillai A, Hunold TM, Vogel A, Patel MS, Singal AG, Tadros M, Feld JJ, Hansen B, Sapisochin G. Surgery, 2026 May 29; 110228 DOI:10.1016/j.surg.2026.110228
      PMID: 42215358
    • Journal Article
      489 PERFORMANCE OF A MULTI-TARGET BLOOD TEST AND ULTRASOUND FOR DETECTION OF HEPATOCELLULAR CARCINOMA ACROSS CLINICAL SUBGROUPS
      John BV, Camardo M, Singal AG, Parikh ND, Yang JD, Roberts LR, Chalasani NP, Salgia R, Kisiel JB, Porter K, Elias PZ, Kielar-Grevstad E, Bruinsma JJ, Olson M, Limburg P. Gastrointestinal Endoscopy, 2026 May 6; 103 (5): s - 1377. DOI:10.1016/s0016-5107(26)03333-x
    • Journal Article
      489 PERFORMANCE OF A MULTI-TARGET BLOOD TEST AND ULTRASOUND FOR DETECTION OF HEPATOCELLULAR CARCINOMA ACROSS CLINICAL SUBGROUPS
      John BV, Camardo M, Singal AG, Parikh ND, Yang JD, Roberts LR, Chalasani NP, Salgia R, Kisiel JB, Porter K, Elias PZ, Kielar-Grevstad E, Bruinsma JJ, Olson M, Limburg P. Gastroenterology, 2026 May 7; 170 (6): s - 1377. DOI:10.1016/s0016-5085(26)03402-5
    • Journal Article
      FRI-061 Hazardous alcohol use amongst persons with compensated cirrhosis from different etiologies: a liver cirrhosis network study
      Khalili M, Gurra M, Simonetto D, Terrault N, Bonner L, Goldberg D, Bajaj J, Sanyal AJ, Welch N, Hameed B, Parikh ND, Tapper E, Loomba R, Tincopa M, Jones P, Verna E, Brown RS, Moylan C, Kamath PS, Kappus MR, Dasarathy S. Journal of Hepatology, 2026 May 28; 84: s116 - s117. DOI:10.1016/s0168-8278(26)00533-7

    Featured News & Stories

    family posing together
    Health Lab

    Doctors perform first liver transplant in Michigan for colon cancer

    Andrew Sweeney was diagnosed with stage 4 colorectal cancer at age 31 and underwent a liver transplant, chemotherapy and radiation treatment.
    Cancer Aware surrounded by a circle of multicolor ribbons
    Cancer Aware

    Cutting edge treatment for advanced colon cancer

    Andrew Sweeney, now 35, was aware of his risk for colorectal cancer – his mother had had been diagnosed with it when she was 41. When he was 31, a CT scan at University of Michigan Health’s University Hospital revealed that Sweeney had a mass in his colon and potential metastases in his liver and lymph nodes. A colonoscopy confirmed that he had stage 4 colorectal cancer. After 1.5 years of chemotherapy, his care team began discussing how they could remove the damaged parts of Sweeney’s liver. They developed a colorectal cancer liver transplant protocol from a deceased donor and Sweeney was the first patient to undergo a liver transplant in Michigan for colon cancer. After minor recurrences of tumors in his lung in 2024, which were treated by surgery and radiation, his scans have been clear.
    Patient receiving histotripsy treatment with health care providers using equipment
    Great Minds, Greater Discoveries Stories

    Research Impact: Histotripsy

    In late 2023, the United States Food and Drug Administration (FDA) approved the use of sound waves to break down tumors — a technique called histotripsy — in humans for liver treatment, a new therapy developed at the University of Michigan and with support from the National Institutes of Health.